Partnerships

 

We are establishing partnerships and high quality research programmes focusing on areas of unmet need which benefit the poorest and most vulnerable populations in Low and Middle Income Countries (LMICs).

We are working with established UK and global funders of health research to support existing, high-quality partnership schemes and co-create new ones in research areas where there is an established and/or unmet need. Working together with funding bodies that have a strong track-record in global health research, we are assuring added value on our funding investment. These high-quality programmes align with DHSC strategic research areas, and are for the primary benefit of the poorest and most vulnerable populations in LMICs. Please see our funding opportunities page for open global health research calls. 

Funded partnerships include:  

Individual calls developed with partner funders

Partners

Call title and link

NIHR contribution

Detail

MRC*, GCRF

Global Maternal and Neonatal Health

Up to £5m

Open

EDCTP

Diagnostic tools for poverty-related diseases challenge

Up to £5m

Stage 2 closes March 2019

MRC

GACD: scaling-up of evidence-based interventions at the population level for the prevention and / or management of hypertension and / or diabetes

Up to £3m

Closed September 2018

DFIDWellcome

Research for Health in Humanitarian Crises (R2HC)

£3.5m

Closed July 2018

EDCTP

Strategic Actions Supporting Large-Scale Clinical Trials

£14.4m

Closed March 2018

EDCTP

Clinical Trials to reduce health inequities in pregnant women, new-borns and children

£12.4m

Closed March 2018

MRC

AMR cross-council Initiative: Antimicrobial Resistance in a Global Context

£6.4m

Closed July 2017 

MRC*, DFID

Research to Improve Adolescent Health in LMIC Settings -call 2

£6m

Closed June 2017

EPSRC

Diagnostics, Prosthetics and Orthotics to Tackle Health Challenges in Developing Countries

£8m

Closed May 2017

MRC

GACD: prevention and management of mental disorders

Up to £1m

Closed April 2017

EDCTP

Research and clinical management of patients in poverty-related disease epidemics in sub-Saharan Africa

£9m

Closed March 2017

EDCTP

Clinical Trials and operational research studies to optimise the use of products for poverty-related diseases in mothers, new-borns, children and adolescents

£8m

Closed March 2017

ESRC

 

AMR cross-council initiative: Behaviour within and beyond the healthcare setting

£3.5m

Closed 2016

*lead partner

 

Partnership Schemes

Joint Global Health Trials

Launched in 2010, the Joint Global Health Trials (JGHT) initiative funds rigorous research to produce implementable evidence addressing questions of major importance to mortality and morbidity in low- and middle-income countries (LMICs), and is jointly funded by the NIHR, the Department for International Development (DFID), the MRC and the Wellcome Trust. Annual calls are open to proposals addressing any major health related problem of particular relevance to LMICs, in particular research addressing chronic non-communicable diseases.

 

Partners 

Partnership title 

NIHR contribution 

Duration 

 

MRC*, DFIDWellcome

 

Joint Global Health Trials Initiative

 

£35m over 5 years

 

Annual call

 See details of the most recent JGHT funding opportunity, Call 9.

 

Global Road Safety Facility

Road traffic accidents are the most common cause of death for young adults, and 90% of these are in low and middle-income countries. The NIHR, together with DFID, is supporting the World Bank’s Global Road Safety Facility, enabling it to scale up its research and capacity building programmes to help these countries tackle the multiple aspects of the road safety challenge, including: data collection; behaviour change, and post-crash care.

Partners

Partnership title 

NIHR contribution 

Duration 

World Bank*,

DFID

Global Road Safety Facility

 £5.3m

3 years

 

 

TDR – AMR SORT IT Initiative


Antimicrobial Resistance (AMR) is a global public health challenge which has the potential to kill as many as 10 million people each year and cost the world economy as much as US$ 100 trillion. The NIHR will partner with the Special Programme for Research and Training in Tropical Diseases (TDR) to deliver the Antimicrobial Resistance Structured Operational Research and Training Initiative (AMR SORT IT), in collaboration with UNICEF, UNDP, WHO and the World Bank. AMR SORT IT will empower LMICs to make better use of the information they collect to make evidence-based decisions and contribute to preventing and controlling the global spread of AMR.

 Partners

Partnership title 

NIHR contribution 

Duration 

 TDR

Antimicrobial Resistance Structured Operational Research and Training Initiative (AMR SORT IT)

£8.2m

3 years

 

Product Development Partnerships (PDPs)

PDPs address the gap between the unmet need for new treatments and other interventions for diseases of poverty in the developing world, and the resources available to develop them. The PDPs bring together partners from academia, industry, the public sector and multilateral agencies to develop effective, affordable, appropriate and accessible products. PDPs have also stimulated increased collaboration of the pharmaceutical industry to work on the diseases of poverty (DoP).

With due consideration of the global need, and in consultation with DfID, the NIHR has made contributions to the following PDPs:

Medicines for Malaria Venture (MMV)

£6.1m

TB Alliance

£4.5m

Foundation for Innovative New Diagnostics (FIND)

£1.2m

 

Vaccines

The NIHR also plays a role in administering ODA funding for the Department of Health and Social Care’s strategic area of Global Health Security. The NIHR ran one competition and administer a second one aimed at developing vaccine candidates, and related technologies and processes, to combat 12 pathogens capable of causing epidemics in LMICs, as identified by the UK Vaccine Network. These competitions were:

  • Research Call for Vaccine development from research groups at MRC/BBSRC Intramural centres. Using £12m ODA funding, proposals were invited for the development of vaccine candidates against the 12 priority pathogens. Successful projects are administered by NIHR.
  • Research Call on Epidemiology for Vaccinology. Using £5m ODA funding, we invited proposals on the use and development of epidemiological models, tools and technologies to assist with the deployment and clinical trialling of vaccines in outbreak situations in LMICs (Closed 2017).

These two competitions are part of a wider programme of work being funded by DHSC. You can find more information about this programme and the UK Vaccine Network here.